Past Tuesday Talks — The AI Frontier: Transforming Health, Medicine & Human Knowledge

Tuesday, January 30, 2023

Presented by Seema Kumar, CEO, Cure

A deep dive with Manolis Kellis about where we really are amidst all the buzz—and hopes and fears and hype—around AI and biomedicine. Dr. Kellis leads one of the top labs in the country at MIT using advanced computing, bioinformatics, and AI to study diseases ranging from obesity to Alzheimer’s. His work focuses on better understanding comparative genomics, epigenetics, genotype-tissue expression, disease mechanisms, and more.

Tuesday Talks — The AI Frontier: Transforming Health, Medicine & Human Knowledge

When: Tuesday, January 30, 2024, 5:30 PM – 7:30 PM ET
Where: Cure, 345 Park Avenue South, New York, NY 10010

Topic: A fireside chat to talk about the buzz—and hopes and fears and hype—around AI and biomedicine, and more.

Speakers: Manolis Kellis, Ph.D., Professor, Computer Science at MIT and head of MIT Computational Biology Group. Moderated by Seema Kumar, CEO of Cure.

Featured Speakers

Manolis Kellis, Ph.D.

About Manolis Kellis, Ph.D.

Manolis Kellis is a Professor of Computer Science at MIT, a member of the Broad Institute of MIT and Harvard, and a member of the Computer Science and Artificial Intelligence Lab at MIT where he directs the MIT Computational Biology Group ( His research is in disease genetics, epigenomics, gene circuitry, non-coding RNAs, comparative genomics, and phylogenetics. He has authored more than 230 journal publications that have been cited more than 115,000 times. He has helped direct several large-scale genomics projects, including the Roadmap Epigenomics project, the comparative analysis of 29 mammals, the human and the Drosophila Encyclopedia of DNA Elements (ENCODE) project, and the Genotype Tissue-Expression (GTEx) project. He received the US Presidential Early Career Award in Science and Engineering (PECASE), the NSF CAREER award, the Alfred P. Sloan Fellowship. He obtained his Ph.D. from MIT, where he received the Sprowls award for the best doctorate thesis in computer science.

Seema Kumar

About Seema Kumar

Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.